Market Tracker

07/23 5:16pm ET

Nymox Pharmaceutical Corp (NASDAQ:NYMX)

5.04
Data as of 4:00pm ET
 -0.01 / -0.20%
Today’s Change
4.40
Today|||52-Week Range
8.19
-16.97%
Year-to-Date

Today’s Trading

Previous close5.05
Today’s open5.06
Day’s range5.01 - 5.15
Volume108,905
Average volume (3 months)75,902
Market cap$177.0M
Dividend yield--
Data as of 4:00pm ET, 07/23/2014

Growth & Valuation

Earnings growth (last year)+39.13%
Earnings growth (this year)0.00%
Earnings growth (next 5 years)--
Revenue growth (last year)+9.32%
P/E ratioNM
Price/Sales61.71
Price/Book--

Competitors

 Today’s
change
Today’s
% change
DRRXDURECT Corp0.000.00%
EGRXEagle Pharmaceutical...-0.46-3.52%
EBIOEleven Biotherapeuti...+0.15+1.33%
TRVNTrevena Inc-0.34-5.58%
Data as of 4:00pm ET, 07/23/2014

Financials

Next reporting dateAugust 15, 2014
EPS forecast (this quarter)-$0.06
Annual revenue (last year)$3.4M
Annual profit (last year)-$4.9M
Net profit margin-146.13%

Profile

Sector
Health Technology
Industry
Medical Specialties
Chairman, President &
Chief Executive Officer
Paul Averback
Chief Financial Officer
André Monette
Corporate headquarters
Saint-Laurent, Quebec

Forecasts